Close
CDMO Safety Testing 2026
Novotech

PeliBioThermal Opens First Network Station in China

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...
- Advertisement -

PeliBioThermal, the life science industryโ€™s cold chain partner from discovery to distribution, announces the opening of its first network station in China. Located in Shanghai, the new network station will serve worldwide customers of the Cr?doโ„ข on Demand rental program.

โ€œChina is the second largest pharmaceutical market in the world, and the country has plans to significantly grow its pharmaceutical industry over the next five years,โ€ said Dominic Hyde, Vice President โ€“ Global Services at PeliBioThermal. โ€œOur new network station will make temperature controlled shipping logistics more convenient for customers doing work in the broader Asia-Pacific region.โ€

China is a growing component in the global market for manufacturing and distribution of pharmaceuticals, including as the leading producer of active pharmaceutical ingredients and a top producer of generic drugs. Through the โ€œMade in China 2025โ€ plan, China aims to further grow its pharmaceutical industry, focusing on drug innovation through research and development.

Chinaโ€™s pharmaceutical market continues to be an area of significant growth. According to the International Trade Administration, Chinaโ€™s pharmaceutical market value reached almost $134 billion in 2018 and is expected to grow to $161.8 billion by 2023.

The Shanghai market is home to several of Chinaโ€™s top 10 pharmaceutical manufacturers including Shanghai Pharmaceuticals and Shanghai Fosun Pharmaceutical, and is a base for world-leading pharma companies including Johnson & Johnson, Roche, Novartis, Pfizer, Bayer, AstraZeneca and GlaxoSmithKline.

Shanghai joins PeliBioThermalโ€™s network of more than 100 network stations and drop points around the world and is the fourth network station in the Asia-Pacific region.

About PeliBioThermal
PeliBioThermal offers the widest range of temperature-controlled packaging and service solutions to the global life sciences industry. The companyโ€™s products ensure that delicate biological materials arrive intact and effective, despite exterior environments. PeliBioThermal is dedicated to developing innovative products designed to fulfill the complex needs of the global life sciences industry. PeliBioThermalโ€™s customers benefit from its extensive expertise in ensuring that temperature stability is maintained throughout the distribution chain. The company also offers a complete portfolio of services and software to support end-to-end temperature-controlled packaging asset management. The companyโ€™s efforts have received recognition including the U.S. Armyโ€™s Greatest Inventions, two UK Queenโ€™s Awards for Enterprise: International Trade in 2018 and Innovation in 2017, the Made in Minnesota Manufacturing award for supply chain innovators and the Finance & Commerce Progress Minnesota award for business growth. PeliBioThermal is a division of Pelican Products, Inc., the global leader in the design and manufacture of high-performance protective cases, advanced portable lighting systems and rugged gear for professionals and outdoor enthusiasts.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...

Avenda Health Expands Unfold AI Into Midwest Cancer Care

Avenda Health said the University of Michigan Health Weiser...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป